UFCM I Care 2017: 6th international conference on the therapeutic use of cannabinoids
The Union Francophone pour les Cannabinoïdes en Médecine (UFCM) is organizing the 6th conference on pharmacological advances and the therapeutic use of cannabinoids on October 20, 2017 in Strasbourg. The event is open to all and will be held from 9am to 5:45pm at Strasbourg's Faculty of Pharmacy.
UFCM is a French association founded by patient and activist Bertrand Rambaud, which promotes and disseminates information on the use of hemp and its derivatives as a medical treatment.
The event is also an opportunity to encourage exchanges between healthcare professionals and patients, and to promote cannabinoid research in French-speaking countries more generally.
The October 20 conference will welcome specialists from all over the world, including France, who will discuss topics such as the personalization of cannabis-based treatments for cancer patients, the use of cannabidiol (CBD) in cases of infantile epilepsy, or the presentation of cannabinoid vaporization equipment with therapeutic approval for herbal medicine by Storz & Bickel (the makers of Volcano).
The complete program is here.
It's always surprising to see such an in-depth conference on the subject in a country whose laws are so harsh on patients who want to treat themselves with cannabis. But France is no stranger to contradictions, and the UFCM's initiative shows that not everyone has given up on the subject.
-
Business2 weeks ago
The legal cannabis market in New York exceeds 4 billion $ in revenue
-
Cannabis in France3 weeks ago
Which countries legalized medical cannabis before France?
-
Business3 weeks ago
South Korea is preparing to begin local production of medical cannabis to meet rising demand
-
Cannabis in Thailand3 weeks ago
From the boom in dispensaries to a purely medical approach: Thailand is revising its cannabis policy
-
Cannabis and driving3 weeks ago
Medical Cannabis and Driving: New South Wales Ends Automatic Penalties for THC
-
Cannabis in Argentina4 weeks ago
Argentina Opens Its Market to Hemp Flowers Containing 1% of THC
-
Autism3 weeks ago
Autism and Cannabis: Results from the First Placebo-Controlled Trial of NTI164
-
Cannabis in France2 weeks ago
France’s Drug Policy Chief Defends Cannabis Prohibition... and Runs Into the Facts


You must be logged in to post a comment Login